Hexobarbital disposition in compensated and decompensated cirrhosis of the liver
- 1 May 1978
- journal article
- research article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 23 (5), 525-534
- https://doi.org/10.1002/cpt1978235525
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Stimulation of drug metabolism by rifampicin in patients with cirrhosis or cholestasis measured by increased hexobarbital and tolbutamide clearanceEuropean Journal of Clinical Pharmacology, 1977
- Effects of liver disease on drug disposition in manBiochemical Pharmacology, 1976
- Pharmacokinetics of ampicillin in cirrhosisClinical Pharmacology & Therapeutics, 1975
- Lidocaine Pharmacokinetics in Advanced Heart Failure, Liver Disease, and Renal Failure in HumansAnnals of Internal Medicine, 1973
- Disappearance Rate of Tolbutamide in Normal Subjects and in Diabetes Mellitus, Liver Cirrhosis, and Renal DiseaseDiabetes, 1963
- USE OF INDOCYANINE GREEN IN MEASUREMENT OF HEPATIC BLOOD FLOW AND AS A TEST OF HEPATIC FUNCTION1961
- PERSISTENCE OF ANTIBIOTICS IN BLOOD OF PATIENTS WITH ACUTE RENAL FAILURE. II. CHLORAMPHENICOL AND ITS METABOLIC PRODUCTS IN THE BLOOD OF PATIENTS WITH SEVERE RENAL DISEASE OR HEPATIC CIRRHOSIS*†JCI Insight, 1959
- Hepatic Circulation in Cirrhosis of the LiverCirculation, 1952